About CCSB
|
News
|
Contact Us
|
Site Map
中文版
CSR
Investor Relations
Events
Contract Research
Contract Manufacturing
API Products
Antifungal
Immunosuppressant
Oncology
Cardiovascular
Peptide Drug
Anti-virus
Immunomodulating Agents
Others
Search Results
Home
> Search Result
Certification
--Please Seclect--
US DMF
CEP / Other DMF
GMP
Inspection
Category
--Please Seclect--
Antifungal
Immunosuppressant
Oncology
Cardiovascular
Peptide Drug
Anti-virus
Immunomodulating Agents
Others
Status
--Please Seclect--
Commercial
Development
Investigation
Completed process development
Products with Certification
Inspection
count:16
Ethyl Icosapentate
86227-47-6
In-house
Commercial
Difelikefalin Acetate
1024829-44-4
In-house
Completed process development
Mycophenolate Mofetil HCl
116680-01-4
In-house
Commercial
Mycophenolate Mofetil
128794-94-5
EP/USP
Commercial
Mycophenolate Sodium
37415-62-6
EP/USP
Commercial
Rapamycin (Sirolimus)
53123-88-9
In-house
Commercial
Tacrolimus
109581-93-3
EP/USP/JP
Commercial
Caspofungin Acetate
179463-17-3
In-house
Commercial
Everolimus
159351-69-6
EP/USP
Commercial
Baricitinib
1187594-09-7
In-house
Completed process development
Palbociclib
571190-30-2
In-house
Completed process development
Ribociclib succinate
1374639-75-4
In-house
Completed process development
Trandolapril
87679-37-6
EP/USP
Commercial
Ozanimod Hydrochloride
1618636-37-5
In-house
Commercial
Sugammadex Sodium
343306-79-6
In-house
Completed process development
Tofacitinib Citrate
540737-29-9
In-house
Commercial